Prédisposition génétique aux cancers du sein et de l'ovaire: Diagnostic moléculaire et conséquences

Translated title of the contribution: Genetic predisposition to breast and ovarian cancer: Molecular diagnosis and consequences

S. Delaloge, L. Albiges, B. Bressac—de Paillerets, A. Chompret

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The molecular diagnosis of a genetic predisposition to breast cancer is now routinely available. BRCA1 and BRCA2 deleterious germline mutations confer very high risks of breast (80% by age 70 years) and ovarian cancer (15-40%). This justifies specific measures of screening, prevention and specific specialized care. The indications, methods and practical consequences of the diagnosis of a genetic predisposition are summarized, and specific care measures presented.

    Translated title of the contributionGenetic predisposition to breast and ovarian cancer: Molecular diagnosis and consequences
    Original languageFrench
    Pages (from-to)213-218
    Number of pages6
    JournalOncologie
    Volume8
    Issue number3
    DOIs
    Publication statusPublished - 1 Jan 2006

    Cite this